Fig. 1
Kaplan–Meier estimates of PFS of advanced G/GEJ cancer patients treated with biweekly SOX. PFS, progression free survival; G/GEJ cancer, gastric or gastroesophageal junction caner
Fig. 1 | BMC Cancer
Kaplan–Meier estimates of PFS of advanced G/GEJ cancer patients treated with biweekly SOX. PFS, progression free survival; G/GEJ cancer, gastric or gastroesophageal junction caner